Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MPA vs Duphaston vs Utrogestan in progestin-primed ovarian stimulation for PCOS undergoing IVF
ChiCTR-IPR-17012998Phase 4Recruiting
- Sponsor
- Shanghai Ninth People's Hospital
- Start
- Nov 2017
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial in female infertility comparing HMG + MPA, HMG + Duphaston and HMG + Utrogestan (3 arms). Primary endpoints: number of oocytes retrieved, maturation rate and 2 more. Started Nov 2017; status: recruiting.
02
Drugs
medroxyprogesterone acetatedydrogesteroneprogesteronehuman menopausal gonadotrophin
03
Conditions
female infertility
Beyond the preview
Go deeper on ChiCTR-IPR-17012998.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-IPR-17012998.